Clear Street Group Inc. Acquires Stake in Tempus AI

Investment firm buys over 700,000 shares of AI healthcare company

Mar. 15, 2026 at 9:51am

Got story updates? Submit your updates here. ›

Clear Street Group Inc. has acquired a new position in Tempus AI, Inc. (NASDAQ:TEM), purchasing 716,406 shares of the company's stock valued at approximately $57.8 million. This represents about 0.41% ownership of Tempus AI, making it the 27th largest holding in Clear Street Group's portfolio.

Why it matters

The acquisition of a significant stake in Tempus AI by Clear Street Group, a prominent investment firm, signals confidence in the potential of the AI-driven healthcare company. Tempus specializes in applying artificial intelligence and machine learning to clinical and molecular data to advance precision medicine, particularly in oncology.

The details

According to a recent SEC filing, Clear Street Group Inc. bought the new position in Tempus AI during the third quarter of the year. The 716,406 shares acquired are valued at approximately $57.8 million. This stake makes Tempus AI the 27th largest holding in Clear Street Group's investment portfolio, accounting for 0.2% of the firm's total holdings.

  • Clear Street Group Inc. acquired the Tempus AI shares during the third quarter of 2026.

The players

Clear Street Group Inc.

An investment firm that has acquired a significant stake in Tempus AI, Inc.

Tempus AI, Inc.

A technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data to advance precision medicine, particularly in oncology.

Got photos? Submit your photos here. ›

The takeaway

The investment by Clear Street Group in Tempus AI underscores the growing importance of AI-driven healthcare solutions and the potential for companies like Tempus to revolutionize precision medicine. This acquisition signals that major investors see significant value in Tempus' technology and its ability to transform cancer treatment through data-driven insights.